210 related articles for article (PubMed ID: 23515732)
1. In vivo study of lyophilized bioprostheses: 3 month follow-up in young sheep.
Taniguchi FP; Maizato MJ; Ambar RF; Pitombo RN; Leiner AA; Moreira LF; Cestari IA; Stolf NA
Rev Bras Cir Cardiovasc; 2012 Dec; 27(4):592-9. PubMed ID: 23515732
[TBL] [Abstract][Full Text] [Related]
2. Behavior of lyophilized biological valves in a chronic animal model.
Maizato MJ; Taniguchi FP; Ambar RF; Pitombo RN; Leirner AA; Cestari IA; Stolf NA
Artif Organs; 2013 Nov; 37(11):958-64. PubMed ID: 24219224
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of lyophilized bioprosthetic valve.
Maizato MJ; Hayashida SA; Taniguchi FP; Higa OZ; Pitombo RN; Cestari IA; Leirner AA; Stolf NA
Artif Organs; 2011 May; 35(5):490-6. PubMed ID: 21595717
[TBL] [Abstract][Full Text] [Related]
4. Lyophilized bovine pericardium treated with a phenethylamine-diepoxide as an alternative to preventing calcification of cardiovascular bioprosthesis: preliminary calcification results.
Aimoli CG; Nogueira GM; Nascimento LS; Baceti A; Leirner AA; Maizato MJ; Higa OZ; Polakiewicz B; Pitombo RN; Beppu MM
Artif Organs; 2007 Apr; 31(4):278-83. PubMed ID: 17437496
[TBL] [Abstract][Full Text] [Related]
5. Decellularization as an anticalcification method in stentless bovine pericardium valve prosthesis: a study in sheep.
Collatusso C; Roderjan JG; Vieira ED; Myague NI; Noronha Ld; Costa FD
Rev Bras Cir Cardiovasc; 2011; 26(3):419-26. PubMed ID: 22086579
[TBL] [Abstract][Full Text] [Related]
6. Effect of SDS-based decelullarization in the prevention of calcification in glutaraldehyde-preserved bovine pericardium: study in rats.
Collatusso C; Roderjan JG; Vieira ED; Costa FD; Noronha Ld; Fornazari Dde F
Rev Bras Cir Cardiovasc; 2012; 27(1):88-96. PubMed ID: 22729305
[TBL] [Abstract][Full Text] [Related]
7. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
Bianco RW; Phillips R; Mrachek J; Witson J
J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
[TBL] [Abstract][Full Text] [Related]
8. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
9. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
10. A novel tissue treatment to reduce mineralization of bovine pericardial heart valves.
Meuris B; De Praetere H; Strasly M; Trabucco P; Lai JC; Verbrugghe P; Herijgers P
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):197-206. PubMed ID: 29572021
[TBL] [Abstract][Full Text] [Related]
11. Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.
Santibáñez-Salgado JA; Olmos-Zúñiga JR; Pérez-López M; Aboitiz-Rivera C; Gaxiola-Gaxiola M; Jasso-Victoria R; Sotres-Vega A; Baltazares-Lipp M; Pérez-Covarrubias D; Villalba-Caloca J
Eur Cell Mater; 2010 Apr; 19():158-65. PubMed ID: 20408127
[TBL] [Abstract][Full Text] [Related]
12. Histological evaluation of biocompatibility of lyophilized bovine pericardium implanted subcutaneously in rats.
Maizato MJ; Pires MD; Canzian M; Higa OZ; Pitombo RN; Leirner AA
Artif Organs; 2008 Apr; 32(4):268-71. PubMed ID: 18370939
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium.
Ohri R; Hahn SK; Hoffman AS; Stayton PS; Giachelli CM
J Biomed Mater Res A; 2004 Aug; 70(2):328-34. PubMed ID: 15227678
[TBL] [Abstract][Full Text] [Related]
14. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
[TBL] [Abstract][Full Text] [Related]
15. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
16. Heat treatment mitigates calcification of valvular bioprostheses.
Carpentier SM; Chen L; Shen M; Fornes P; Martinet B; Quintero LJ; Witzel TH; Carpentier AF
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S264-6. PubMed ID: 9930461
[TBL] [Abstract][Full Text] [Related]
17. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
18. L-glutamic acid in the prevention of the calcification of bovine pericardial fixed in glutaraldehyde: study in rats.
Ferreira AD; Costa FD; Santos EA; Sardeto EA; Gomes CH; Collatusso C; Lopes SA; Perruzzo A; Costa Ide S
Rev Bras Cir Cardiovasc; 2007; 22(3):303-9. PubMed ID: 18157416
[TBL] [Abstract][Full Text] [Related]
19. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
[TBL] [Abstract][Full Text] [Related]
20. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
